Press Releases

Get the latest on BIO’s announcements, positions, and views.

Featured Press Releases
BIO Statement on Passage of Bipartisan…
WASHINGTON, D.C. –  John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement.“The passage of the Mikaela Naylon Give Kids a Chance Act is a bipartisan victory for children and…
BIO Appoints Joe Franklin, JD, PhD, as Chief…
Washington, D.C. (February 2, 2026) -- The Biotechnology Innovation Organization (BIO) today named Joe Franklin, JD, PhD, as its new chief legal and policy officer. Franklin brings deep expertise in the biomedical sector across law, policy, AI, and…
Biotechnology Innovation Organization (BIO)…
WASHINGTON, DC (January 7th, 2026) – Today, the Biotechnology Innovation Organization (BIO) announced the launch of the BIO Investment Council (BIC). The newly established council aims to serve small and emerging biotech innovators by increasing…
All Press Releases
  • Show All
Search
Results
Event Tags
August 29, 2019
Event Brought Together Biopharma Executives and Investors from Around the World for Deal Making and Partnering Opportunities
August 11, 2019
Washington, D.C. (August 10, 2019) –The Biotechnology Innovation Organization (BIO) released the following statement on the administration’s decision to issue 31 small refinery exemptions under the Renewable Fuel Standard. “The administration…
August 5, 2019
The Biotechnology Innovation Organization (BIO) today put forward a consumer-friendly proposal that would improve public access to information about new agricultural biotechnology products. Combined with a new science-based regulatory approach, BIO…
July 31, 2019
Following the introduction of the Trump administration’s drug importation proposal, BIO’s President and CEO Jim Greenwood issued the following statement: “There is simply no way to adopt an importation scheme that doesn’t jeopardize the health and…
July 23, 2019
Washington, DC (July 23, 2019) – Following the release of the Senate Finance Committee’s drug pricing proposal, Tom DiLenge, the Biotechnology Innovation Organization’s President of Advocacy, Law & Public Policy Division issued the…
July 23, 2019
Washington, DC (July 23, 2019) – Today, legislation that would significantly improve the ability of emerging biotechnology companies to focus their investor capital on science and biomedical innovation was introduced in the House of…
July 11, 2019
As presidential candidates trek across the Hawkeye State and campaign on addressing society’s most pressing challenges, biotech innovators wrapped up four days of showcasing the scientific solutions to climate change, hunger, pollution and energy…
July 11, 2019
BIO’s President and CEO Jim Greenwood issued the following statement after it was reported that the Trump administration is withdrawing its proposed rebate rule that would have required savings from drugmakers' rebates be passed along to…
July 10, 2019
Strong patent rights are essential to finance the revolution in biotechnology discoveries from the lab to the patient, farmer, and consumer
July 8, 2019
Washington, D.C. (July 5, 2019) – The Biotechnology Innovation Organization (BIO) released the following statement on the U.S. Environmental Protection Agency’s (EPA) proposed Renewable Fuel Standard (RFS) volumes for 2020. “EPA’s proposal to…
gooddaybio-cover-final
Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.